October 5, 2018 / 11:08 PM / 6 months ago

Boehringer wins third trial over Pradaxa bleeding risks

A Connecticut jury on Friday cleared Boehringer Ingelheim of liability in a lawsuit alleging its blood thinner Pradaxa caused a man to suffer severe bleeding, the company said.

The verdict by a Hartford Superior Court jury marked the latest defense victory in litigation over the company’s blockbuster drug. It came following a three-week trial in a 2016 lawsuit by William Bedsole, who accused Boehringer of failing to warn doctors, including his own, of the risks associated with taking Pradaxa.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2Ob3b9S

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below